Literature DB >> 3436339

Absorption of intramuscularly administered [14C]haloperidol decanoate in rats.

Y Matsunaga1, K Nambu, Y Oh-e, H Miyazaki, M Hashimoto.   

Abstract

When [14C]haloperidol decanoate, an ester of haloperidol and decanoic acid, was given intramuscularly to rats, levels of total radioactivity and haloperidol decanoate in medial iliac and hypogastric sacral lymph nodes nearest to injection sites were the highest in examined lymph nodes and plasma. These lymph node levels became maximum 16 days after administration and declined gradually with half-life (around 14 days) similar to those of plasma total radioactivity, haloperidol decanoate and haloperidol. However, when the labelled ester was given intravenously, plasma total radioactivity disappeared far more rapidly. Much more radioactivity was found in hind limbs whose femoral muscles had been injected than in other body parts, even at late stages after administration. Haloperidol alone was found in the brain after [14C]haloperidol decanoate was given either intramuscularly or intravenously. It was concluded that haloperidol decanoate injected in rat femoral muscle was rate-limitedly distributed in lymph circulation and that the absorbed ester did not penetrate the brain through the blood-brain barrier but formed haloperidol did.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436339     DOI: 10.1007/BF03189894

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  9 in total

Review 1.  The long-acting neuroleptics: a retrospective appraisal.

Authors:  H L Yale
Journal:  Drug Metab Rev       Date:  1978       Impact factor: 4.518

2.  Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. I. Absorption, distribution, and excrection of [14C]tolmetin radioactivity.

Authors:  M Hashimoto; H Miyazaki; T Fujii; K Nambu; K Tanaka
Journal:  Drug Metab Dispos       Date:  1979 Jan-Feb       Impact factor: 3.922

Review 3.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

4.  Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.

Authors:  J Dreyfuss; J M Shaw; J J Ross
Journal:  J Pharm Sci       Date:  1976-09       Impact factor: 3.534

5.  Differential effects of haloperidol decanoate, a long-acting neuroleptic, in behavioral and biochemical tests.

Authors:  M Oka; T Karasawa; Y Ochi; K Asano; Y Terauchi; T Kadokawa
Journal:  Arch Int Pharmacodyn Ther       Date:  1985-10

6.  Enzymatic hydrolysis of haloperidol decanoate and its inhibition by proteins.

Authors:  K Nambu; H Miyazaki; Y Nakanishi; Y Oh-e; Y Matsunaga; M Hashimoto
Journal:  Biochem Pharmacol       Date:  1987-05-15       Impact factor: 5.858

7.  Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.

Authors:  Y Matsunaga; K Nambu; Y Oh-e; H Miyazaki; M Hashimoto
Journal:  Arzneimittelforschung       Date:  1986-03

8.  Disposition and metabolism of [14C]-haloperidol in rats.

Authors:  H Miyazaki; Y Matsunaga; K Nambu; Y Oh-e; K Yoshida; M Hashimoto
Journal:  Arzneimittelforschung       Date:  1986-03

9.  Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study.

Authors:  R Deberdt; P Elens; W Berghmans; J Heykants; R Woestenborghs; F Driesens; A Reyntjens; I van Wijngaarden
Journal:  Acta Psychiatr Scand       Date:  1980-10       Impact factor: 6.392

  9 in total
  3 in total

Review 1.  Critical factors influencing the in vivo performance of long-acting lipophilic solutions--impact on in vitro release method design.

Authors:  Susan Weng Larsen; Claus Larsen
Journal:  AAPS J       Date:  2009-11-06       Impact factor: 4.009

2.  Hydrolysis of haloperidol decanoate in vitro by cultured cells.

Authors:  Y Oh-e; H Miyazaki; Y Matsunaga; K Nambu; N Kobayashi; M Hashimoto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jul-Sep       Impact factor: 2.441

3.  The roles of depot injection sites and proximal lymph nodes in the presystemic absorption of fluphenazine decanoate and fluphenazine: ex vivo experiments in rats.

Authors:  J P Luo; J W Hubbard; K K Midha
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.